IMAC Holdings Net Income 2018-2024 | BACK

IMAC Holdings net income from 2018 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
IMAC Holdings Annual Net Income
(Millions of US $)
2023 $-9
2022 $-18
2021 $-11
2020 $-6
2019 $-6
2018 $-3
2017 $-0
IMAC Holdings Quarterly Net Income
(Millions of US $)
2024-03-31 $-0
2023-12-31 $-1
2023-09-30 $-3
2023-06-30 $-1
2023-03-31 $-4
2022-12-31 $-7
2022-09-30 $-6
2022-06-30 $-2
2022-03-31 $-3
2021-12-31 $-3
2021-09-30 $-3
2021-06-30 $-3
2021-03-31 $-2
2020-12-31 $-0
2020-09-30 $-1
2020-06-30 $-2
2020-03-31 $-2
2019-12-31 $-1
2019-09-30 $-2
2019-06-30 $-2
2019-03-31 $-2
2018-12-31 $-1
2018-09-30 $-1
2018-06-30 $-1
2018-03-31 $-0
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.001B $0.016B
IMAC Holdings Inc. is a provider of regenerative rehabilitation orthopedic treatments without the use of surgery or opioids. It owns or manages outpatient clinics which provide regenerative, orthopedic and minimally invasive procedures and therapies. The company's outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids. IMAC Holdings Inc. is based in BRENTWOOD TN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00